Contract Pharmaceutical Dose Manufacturing Industry - Composition, Size, Market Share and Outlook, 2023 Edition
Summary
This expert trend report is a comprehensive look at the pharmaceutical finished dose contract manufacturing landscape in 2023, including analysis of dose CMO M&A activity, market size and share. It is a critical source for strategic planning efforts and will improve understanding of crucial components of the supply chain that will provide insights for supplier selection and management.
This expert trend report is a comprehensive look at the finished dose contract manufacturing landscape in 2023, including analysis of dose CMO M&A activity, market size and share. It is a critical source for strategic planning efforts and will improve understanding of crucial components of the supply chain that will provide insights for supplier selection and management.
Scope
This 63-page report gives an important expert quantitative analysis on the pharmaceutical commercial contract dose manufacturing industry. Findings are based on the industry’s most comprehensive database of the dose CMO industry (GlobalData's Contract Service Providers Database). This analysis is driven by a proprietary model of the dose manufacturing industry, which is continuously updated and refined. The 8 tables and 20 figures throughout the report illustrate major points and trends. This report is required reading for -
- CMO executives and strategic decision-makers: to improve understanding of the dose CMO industry and provide a critical input for strategic planning efforts.
- Sourcing and procurement executives in bio/pharmaceutical companies: to improve understanding of crucial components of the supply base that will provide insights for supplier selection and management.
- Private equity investors: they can gain a deeper understanding of the dose CMO market and important insights for identifying potential investment targets.
This report will enable the user to answer the following questions -
- What is the geographic reach of commercial dose CMOs?
- What are revenues did the commercial contract dose manufacturing industry generate in the last year?
- What are the components of revenue change for contract dose manufacturers?
- What is the breakdown of 2022 revenues by different dosage forms?
- What are the characteristics of the largest dose CMOs?
- How did the revenue growth of Contract Dose manufacturers in 2022 compare to Contract API manufacturers?
- What is the outlook for the dose CMO industry?
- What is the outlook for COVID-19 products?
- Executive Summary
- Players
- Table Figure 1: Leading dose CMOs, 2022
- Trends
- Table Figure 2: Top contract dose trends in the CMO industry, 2022
- Table Dose CMO trends, 2022
- Industry Size and Structure
- Definition of the dose CMO universe
- Industry demographics
- Global versus regional reach
- Table Figure 3: Geographic reach of the dose CMO universe, 2022
- Table Figure 4: Geographic distribution of commercial dose facilities, 2022
- Dosage forms
- Table Figure 5: Geographic distribution of commercial dose injectable facilities, 2022
- Table Figure 6: CMO count by dose revenue tiers, 2022
- Global versus regional reach
- Major developments affecting industry structure
- Dose facility acquisitions
- Table Summary of CMO facility acquisition of dose facilities activity, 2013-22
- Table CMO acquisitions of dose manufacturing facilities, 2022
- Dose company acquisitions
- Table Dedicated CMO acquisitions of companies with commercial dose capabilities, 2022
- PE acquisitions
- Table PE investments in the dose CMO industry, 2013-22
- Dose facility acquisitions
- Industry Size and Growth
- Dose manufacturing
- Inflation
- Components of growth
- Table Figure 7: Dose CMO revenue, 2011-22
- Table Figure 8: Components of growth for dose CMOs, 2021-22
- Revenue by dosage form
- Table Figure 9: Dose CMO dosage form revenue segments in 2022 ($B)
- Table Figure 10: Dose CMO dosage form revenue segments percentage change from 2021-22 (%)
- Dose manufacturing
- CMO Market Shares
- Table Figure 11: Dose CMO industry market share by company revenue tier, 2022
- Table Figure 12: Dose CMO industry market share by company revenue tier, percentage change from 2021-22 (%)
- Characteristics of the largest CMOs
- Table Dose revenue composition and strategic orientation of leading CMOs, 2022
- COVID-19 Products Sales Forecast
- Table Figure 13: COVID-19 vaccines sales forecasts, 2022-26
- Table Figure 14: COVID-19 therapy sales forecasts, 2022-26
- Analyzing Recent Dose CMO Industry Performance
- COVID-19 influence
- Table Figure 15: COVID-19 vaccine and therapy contract manufacturing agreements
- High inflation effect
- Service-specific growth
- Cell and gene therapy investment
- Table Figure 16: CMO services sector performance, 2022
- Table Figure 17: Revenue growth for public CMOs
- Sponsor-CMO relationships
- Table Figure 18: Small, micro, and nano cap sponsors' dose outsourcing propensity for NMEs, 2013-22
- Table Figure 19: Breakdown in composition of dose-outsourced NMEs, by sponsor market cap, 2013-22
- COVID-19 influence
- What It Means
- Value Chain
- Table Figure 20: The contract manufacturing value chain
- Companies
- Table Geographical reach of dose CMO universe, 2022
- Appendix
- Methodology
- Methodology for market size and growth estimates
- Deals years
- CMO classifications
- Bibliography
- Primary research - key opinion leaders
- Further reading
- Table Further reading
- Methodology
- About the Authors
- Contact Us
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook